Depression and SSRI Treatment During Pregnancy

Дата публикации: 01-10-2026 00:00:00

This Special Communication outlines current evidence regarding effects of both major depressive disorder and selective serotonin reuptake inhibitor (SSRI) treatment on pregnancy and offspring outcomes and advocates for evidence-informed treatment decisions.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	expert reaction to a population cohort study on prenatal exposure to maternal depression and antidepressants and neurodevelopmental outcomes	0	8.32	29-09-2026
2	Racial and Ethnic Disparities in OUD Treatment Discontinuation Among Pregnant Females	0	4.21	01-10-2026
3	Medication and Procedural Abortion and Risk of Psychotropic Medication Use	0	6.88	01-10-2026
4	Longitudinal Precision Functional Mapping in Psychiatry	0	3.6	01-10-2026
5	How Should We Interpret the Association Between Abortion and Mild Psychiatric Illness?	0	7.52	01-10-2026
6	Blinding Integrity and Psychedelic Drug Trials	0	17.3	01-10-2026
7	Blinding Integrity and Psychedelic Drug Trials	0	12.75	01-10-2026
8	A Plea for Intravenous Iron in Pregnancy—Delivering Results	0	10	23-09-2026
9	Минздрав представил обновленный стандарт лечения депрессии	0	10	27-09-2026
10	RSV Bivalent Prefusion F Protein Vaccine in Pregnancy	0	11.82	08-09-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 8.77. Источник: archderm.jamanetwork.com.